Stock & Company Details
Arbutus Biopharma Corp $ABUS
Price:
46,691,331
198M
$871M
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
-9.89
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
ABUS technical indicators
Latest Arbutus Biopharma Corp (ABUS) technical indicators as of 2026-07-21: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
46.32 9.3%
MACD:
0.02 44.5%
SMA 50:
$4.51 0.1%
SMA 200:
$4.45 0.0%
EMA 20:
$4.65 0.3%
Bollinger Bands:
5.21 / 4.23
Stochastic:
9.29 42.6%
ADX 14:
20.55 6.3%
ATR 14:
0.22 3.1%
CCI 20:
-78.94 13.3%
OBV:
109.44M 2.1%
ROC 12:
-7.19% 6.2%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.
Finance Bot
Ask your questions
Start by typing a question below.
